BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Fortress Biotech
FBIO
$91.4M
| $10.6K | ﹤0.01% |
198
-383
| -66% | -$23.1K |
|
|
SAL
3577
DELISTED
Salisbury Bancorp, Inc.
SAL
| $10.5K | ﹤0.01% |
414
-2,044
| -83% | -$47K |
|
|
EVLO
3578
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $10.5K | ﹤0.01% |
38
-94
| -71% | -$23.7K |
|
3579
Distribution Solutions Group
DSGR
$1.61B
| $10.5K | ﹤0.01% |
392
-1,864
| -83% | -$51.4K |
|
|
QTNT
3580
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $10.5K | ﹤0.01% |
72
-164
| -69% | -$26.2K |
|
3581
BCB Bancorp
BCBP
$161M
| $10.4K | ﹤0.01% |
772
-6,505
| -89% | -$89.8K |
|
|
LMST
3582
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
| $10.4K | ﹤0.01% |
624
-1,770
| -74% | -$28.3K |
|
|
IEA
3583
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
| $10.4K | ﹤0.01% |
+805
| New | +$10.1K |
|
3584
OP Bancorp
OPBK
$235M
| $10.3K | ﹤0.01% |
1,028
-5,228
| -84% | -$54.7K |
|
3585
MainStreet Bancshares
MNSB
$177M
| $10.3K | ﹤0.01% |
455
-2,854
| -86% | -$61.3K |
|
3586
SAP
SAP
$236B
| $10.1K | ﹤0.01% |
72
-342
| -83% | -$47.6K |
|
|
INFI
3587
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $10.1K | ﹤0.01% |
+3,371
| New | +$10.7K |
|
3588
Eton Pharmaceutcials
ETON
$1.14B
| $10.1K | ﹤0.01% |
1,633
-526
| -24% | -$3.9K |
|
|
ESSA
3589
DELISTED
ESSA Bancorp
ESSA
| $10K | ﹤0.01% |
612
-3,671
| -86% | -$58.3K |
|
|
ITI
3590
DELISTED
Iteris, Inc.
ITI
| $10K | ﹤0.01% |
1,508
-3,808
| -72% | -$25.7K |
|
3591
Dianthus Therapeutics
DNTH
$6.29B
| $9.98K | ﹤0.01% |
64
-137
| -68% | -$25.2K |
|
3592
Colony Bankcorp
CBAN
$467M
| $9.91K | ﹤0.01% |
555
-3,552
| -86% | -$59.6K |
|
|
AGS
3593
DELISTED
PlayAGS
AGS
| $9.87K | ﹤0.01% |
997
-10,560
| -91% | -$97.4K |
|
3594
SB Financial Group
SBFG
$174M
| $9.86K | ﹤0.01% |
560
-3,161
| -85% | -$55.8K |
|
|
FNCB
3595
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $9.84K | ﹤0.01% |
1,353
-7,419
| -85% | -$53.8K |
|
3596
Pixelworks
PXLW
$42.3M
| $9.79K | ﹤0.01% |
239
-223
| -48% | -$8.75K |
|
|
URG
3597
Ur-Energy
URG
$537M
| $9.76K | ﹤0.01% |
+6,969
| New | +$9.52K |
|
3598
Avalo Therapeutics
AVTX
$1.05B
| $9.75K | ﹤0.01% |
1
-1
| -50% | -$8.38K |
|
3599
Suncor Energy
SU
$74.7B
| $9.73K | ﹤0.01% |
406
| – | – |
|
3600
Asure Software
ASUR
$241M
| $9.73K | ﹤0.01% |
1,097
-10,037
| -90% | -$82.3K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.